National brain tumour research funding needs to increase to £35 million a year
Brain Tumour Research returns to Westminster
Brain Tumour Research is back at Westminster today for the first face-to-face meeting of the All-Party Parliamentary Group on Brain Tumours (APPGBT) since the start of the pandemic.
The APPGBT seeks to break down barriers on the pathway to a cure for brain tumours. Throughout 2022, Brain Tumour Research – in its role of secretariat to the APPGBT – has asked questions to help determine what these barriers are.
At today’s meeting, our Head of Stakeholder Relations Hugh Adams will provide parliamentarians with an update on the inquiry, Pathway to a Cure – breaking down the barriers, following the collation of written evidence, a patient survey and six oral evidence sessions.
Attendees will also hear from Hilary Duckworth, Novocure UK & Ireland Country Manager, on Tumour Treating Fields, what these could offer for brain tumour patients in the UK and what could be the route to the UK market. The Brain Tumour Charity will present on the charity’s Better Safe Than Tumour awareness campaign.
We will provide a fuller update on what happened at the APPGBT meeting in our e-news on Friday. To sign up to receive our weekly e-news, for all the latest campaign, research and fundraising news from Brain Tumour Research, please visit www.braintumourresearch.org/subscribe
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.